June 4, 2026
Caleres (CAL): What the Q1 Numbers Are Actually Saying
Suspended guidance, margin pressure, and one cost plan worth watching
Caleres (CAL): Q1 Results Are In
Sales came in at $614.2 million. Down 6.8% year-over-year. Gross margin compressed to 45.4%, off 152 basis points from the same quarter last year. Diluted EPS printed at $0.21, compared to $0.88 in Q1 2024. And then management did something that tends to reset the entire conversation around a stock — they pulled full-year guidance completely, pointing to tariff uncertainty and a consumer spending backdrop that is harder to model than it was six months ago.
That last part matters more than the margin miss.
When a company suspends guidance, the market does not just reprice the next quarter. It reprices the information environment entirely. Traders are no longer working with a guardrail. Every data point becomes a signal because there is no anchor range to dismiss it against. That creates volatility in both directions, and it is something to respect in sizing decisions before Q2 results hit.
Here is the thing about the segment breakdown though — neither Famous Footwear nor the Brand Portfolio escaped Q1 clean. Famous Footwear posted a 6.3% sales decline, with comparable sales down 4.6%. The Brand Portfolio segment, which includes Naturalizer, LifeStride, Dr. Scholl’s, and Blowfish Malibu, fell 6.9% to $295.4 million from $317.2 million a year ago. Gross profit dropped $30.4 million to $278.7 million. Operating earnings came in at $11.6 million versus $42.8 million in Q1 2024.
February was weak. March and April were better. Not enough to recover the quarter, but the directional shift is there — and that is actually what makes this more interesting than the headline suggests.
A little-known decision from the 1930s changed the value of gold overnight.
Now, some analysts believe a similar conversation is quietly resurfacing.
Whether it leads anywhere remains to be seen.
But the history behind it is fascinating.
A new report explains what happened, why it mattered, and why some investors are paying attention again today.
Read The Great Gold Reset here.
What I am watching more than anything right now is the $15 million SG&A reduction management committed to. Annualized. With $7.5 million expected to flow through fiscal 2025 specifically. For a company operating on thin margins in a deleverage environment, that is not a footnote — it is the mechanism that either changes the back-half earnings math or does not. There is no middle ground there.
Slight tangent, but it matters: the DTC channel was approximately 72% of total net sales in fiscal 2024. That is actually a structural advantage that does not get enough attention when the headline numbers are soft. A predominantly DTC business controls its own promotional cadence, its own inventory decisions, its own customer data. In a tariff environment where cost unpredictability is running high, that control matters more than it did when supply chains were stable.
The sourcing diversification story is also moving faster than expected. Caleres has guided to China representing 10% or less of total sourcing dollars in the second half of 2025. That is a significant structural shift. Whether it shows up meaningfully in Q2 gross margins is the real test — announcements are easy, cost structure changes take time to surface in reported numbers.
Full-year adjusted EPS guidance sits at $0.55 to $0.60. GAAP guidance is a loss of $0.13 to $0.18 per diluted share, partly because the Stuart Weitzman integration is expected to dilute EPS by $0.60 to $0.65 this year. That integration drag is worth keeping in a separate mental bucket from the core operating performance — conflating them tends to lead to sloppy analysis in either direction.
Trump named it. Scientists built it. Here’s what it means for you.
The name is “Golden Dawn.” That’s what President Trump’s team is calling America’s new Manhattan Project – but for AI. It will span more than 700 miles – making it by far the largest AI infrastructure project ever built. When Trump flips the on switch, Louis Navellier believes it will trigger a $100 trillion reset of the AI markets. For investors who get ahead of it, the timing could mean everything.
Louis’ revealing the one stock at the center of it all right here.
Three things I am keeping close tabs on heading into Q2:
- Comparable sales trend in May and June — is the March/April improvement holding or was it a blip
- Whether the China sourcing shift begins showing up in merchandise margin, not just in management commentary
- Any signal around guidance reinstatement — that alone could reprice the stock faster than any single data point
What matters is the gap between execution pace and investor patience. Caleres has identified what needs to happen. The cost plan is real. The sourcing pivot is in motion. But the market does not reward plans — it rewards evidence that plans are working. That evidence is still several weeks away at minimum.
Position sizing accordingly. The suspended guidance is not a death sentence for the stock — but it does mean conviction needs to earn its place. Worth a close look before Q2 lands.
For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.
